Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease

Naltrexone is an approved drug for management of alcohol use disorder (AUD), but data in patients with liver disease (LD) are limited. We aimed to evaluate the safety of naltrexone in those with LD. This is a retrospective cohort of adults with and without LD who were prescribed naltrexone for AUD f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayyala, Divya, Bottyan, Thomas, Tien, Christine, Pimienta, Michael, Yoo, Jennie, Stager, Kelli, Gonzalez, Jose Luis, Stolz, Andrew, Dodge, Jennifer L., Terrault, Norah A., Han, Hyosun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701476/
https://www.ncbi.nlm.nih.gov/pubmed/36281979
http://dx.doi.org/10.1002/hep4.2080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701476/
https://www.ncbi.nlm.nih.gov/pubmed/36281979
http://dx.doi.org/10.1002/hep4.2080

Ejemplares similares